CES 2026 offered a glimpse of a future that feels straight out of a sci-fi movie: bendable screens, paper-thin TVs and<a class="excerpt-read-more" href=" More ...

Farran Powell is the managing editor of investing at Forbes Advisor. She was previously the assistant managing editor of investing at U.S. News & World Report. Her work has appeared in numerous ...

Farran Powell is the managing editor of investing at Forbes Advisor. She was previously the assistant managing editor of investing at U.S. News & World Report. Her work has appeared in numerous ...

If you're interested in exploring more stocks under $10 get an edge over other traders with Benzinga Pro while we're currently offering a 14-day trial. Investing in stocks under $10 could ...

Growth stocks are made up of companies that are set to grow their earnings and revenue by an abundant amount compared to the rest of the market, which also has an impact on the price of each company’s ...

Perhaps you've heard rumors about the death of physical media. Those rumors are greatly exaggerated. Tons of 4K UHD and Blu-ray movies and TV shows hit the shelves each month. And with all the ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Vaccine stocks remain lucrative, with ongoing revenue from both COVID-19 and other vaccines. Before investing, assess a company's market products, regulatory status, and potential issues. Research ...

CBD industry's potential limited by FDA exclusion from food supplements and uncertain regulations. Jazz Pharmaceuticals stands out with FDA-approved CBD drug Epidiolex, nearing $1 billion sales.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...